Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Firmagon (Degarelix) Intermittent Therapy (FIT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by Canadian Urology Research Consortium
Sponsor:
Collaborator:
Ferring Pharmaceuticals
Information provided by (Responsible Party):
Canadian Urology Research Consortium
ClinicalTrials.gov Identifier:
NCT01512472
First received: November 10, 2011
Last updated: November 30, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)